Login / Signup
Ryoko Seki
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 1
Top Topics
Clinical Trial
Open Label
Top Venues
Cancer research communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Takafumi Koyama
,
Kan Yonemori
,
Toshio Shimizu
,
Jun Sato
,
Shunsuke Kondo
,
Kazuki Sudo
,
Tatsuya Yoshida
,
Yuki Katsuya
,
Tatsuki Imaizumi
,
Masashi Enomoto
,
Ryoko Seki
,
Noboru Yamamoto
Phase 1 study of simlukafusp alfa (FAP-IL2v) with or without atezolizumab in Japanese patients with advanced solid tumors.
Cancer research communications
(2024)